You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / SANOFI INDIA

SANOFI INDIA
Intrinsic Value | Fundamental Analysis

Returns | 1W : -0.2% , 1M : -4.3%,1Y : -3%
BOM : 500674     NSE : SANOFI    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
May 14,2021
Price(EOD): Rs. 7,747.55
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 17,819.37 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
SANOFI INDIA -0.2% -4.3% -3%
SUN PHARMACEUTICAL INDUSTRIES 1.7% 11.6% 51.5%
DR REDDYS LABORATORIES 0.4% 4.1% 40.6%
DIVIS LABORATORIES -0.2% 6.3% 71.8%
CIPLA 2.4% 0.1% 57.7%
BIOCON 2.1% -3.8% 12.2%
AUROBINDO PHARMA -0.6% 9.9% 47.1%
LUPIN -1.4% 12.7% 42.7%
TORRENT PHARMACEUTICALS 4.1% 6.5% 11.5%


FUNDAMENTAL ANALYSIS OF SANOFI INDIA

 
Fundamentals Score
[Last Annual Data : Dec2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than SANOFI INDIA Premium


VALUATION OF SANOFI INDIA

 
Valuation Score
Ratio Standalone
P/E
P/B
P/S
37.31
P/E Calculated based on EPS of 207.65
[ Dec2020 - Standalone Results ]

8.63
P/B Calculated based on Book Value of 897.83
[ Dec2020 - Standalone Results ]

5.75
P/S Calculated based on Revenues of 3100.4 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than SANOFI INDIA Premium


FAIR VALUE OF SANOFI INDIA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
69%
35%
38%

SHARE PRICE MOMENTUM OF SANOFI INDIA

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0
0
0
-
-
-
-
-
[Last Annual Data : Dec2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Mar2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
0.67%
13.41%
14.51%
18.62%
-7.57%
7.19%
44.8%
70.84%
QtrlyTrend
6
Latest Qtr: Mar2021

SANOFI INDIA related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 0.2% 6.8% 61%
S&P BSE SMALL CAP -0.1% 8% 112.6%
S&P BSE MIDSMALLCAP -0.3% 6.2% 97.6%
S&P BSE 400 MIDSMALLCAP -0.4% 6.1% 98.4%
S&P BSE ALLCAP -0.7% 4% 68.7%
S&P BSE 500 -0.7% 3.8% 67.2%
S&P BSE 200 -0.8% 3.5% 64.2%
S&P BSE 250 LARGEMIDCAP -0.8% 3.5% 64.6%
S&P BSE 150 MIDCAP -0.9% 5.1% 90.8%
S&P BSE SMALLCAP SELECT INDEX -1.4% 4.6% 96.2%
NSE Indices1W1M1Y
NIFTY DIV OPPS 50 0.6% 3.2% 54.9%
NIFTY MNC 0.5% 2.9% 36.3%
NIFTY MID SMALL400 -0.3% 6.2% 99.8%
NIFTY MIDCAP150 -0.7% 4.9% 90.7%
NIFTY 500 -0.7% 3.7% 66.7%
NIFTY FREE MIDCAP 100 -0.7% 5.4% 94%
NIFTY LARGE MIDCAP 250 -0.8% 4% 74.5%
NIFTY 200 -0.8% 3.4% 63.1%

FAQ [Frequently Asked Questions]


Is SANOFI good for long term investment?

As on 14-May-2021, the Fundamentals of SANOFI are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of SANOFI INDIA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SANOFI UnderValued or OverValued?

As on 14-May-2021, SANOFI is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SANOFI ?

As on 14-May-2021, the Intrinsic Value of SANOFI is Rs. 5,603.30 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 4,596.74
Fair Value [Median EV / Sales Model] : Rs. 5,733.22
Fair Value [Median Price / Sales Model] : Rs. 5,603.30
Median Fair Value of SANOFI : Rs. 5,603.30

Is SANOFI trading at a Premium or Discount?

As on 14-May-2021, SANOFI is trading at a Premium of 38% based on the Median Intrinsic Value!

Is it right time to buy SANOFI shares?

As on 14-May-2021, SANOFI is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of SANOFI?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with SANOFI?

SANOFI INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
SANOFI INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
SANOFI INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
SANOFI INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
SANOFI INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
SANOFI INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
SANOFI INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
SANOFI INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
SANOFI INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z